GSK Plc (GSK)
50.82
+0.55
(+1.09%)
USD |
NYSE |
Aug 28, 16:00
50.84
+0.02
(+0.04%)
After-Hours: 20:00
GSK Free Cash Flow : 6.621B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.621B |
| March 31, 2026 | 5.741B |
| December 31, 2025 | 5.712B |
| September 30, 2025 | 5.646B |
| June 30, 2025 | 5.470B |
| March 31, 2025 | 4.392B |
| December 31, 2024 | 4.012B |
| September 30, 2024 | 5.358B |
| June 30, 2024 | 5.846B |
| March 31, 2024 | 5.957B |
| December 31, 2023 | 4.953B |
| September 30, 2023 | 3.164B |
| June 30, 2023 | 1.912B |
| March 31, 2023 | 2.260B |
| December 31, 2022 | 5.333B |
| September 30, 2022 | 8.432B |
| June 30, 2022 | 9.386B |
| March 31, 2022 | 8.945B |
| December 31, 2021 | 6.248B |
| September 30, 2021 | 5.771B |
| June 30, 2021 | 4.152B |
| March 31, 2021 | 6.067B |
| December 31, 2020 | 6.930B |
| September 30, 2020 | 6.350B |
| June 30, 2020 | 8.671B |
| Date | Value |
|---|---|
| March 31, 2020 | 6.750B |
| December 31, 2019 | 6.384B |
| September 30, 2019 | 7.726B |
| June 30, 2019 | 7.257B |
| March 31, 2019 | 7.709B |
| December 31, 2018 | 8.014B |
| September 30, 2018 | 6.125B |
| June 30, 2018 | 5.834B |
| March 31, 2018 | 4.976B |
| December 31, 2017 | 5.143B |
| September 30, 2017 | 5.278B |
| June 30, 2017 | 5.209B |
| March 31, 2017 | 5.818B |
| December 31, 2016 | 4.741B |
| September 30, 2016 | 3.032B |
| June 30, 2016 | 1.282B |
| March 31, 2016 | -181.84M |
| December 31, 2015 | 15.34M |
| September 30, 2015 | 1.414B |
| June 30, 2015 | 2.761B |
| March 31, 2015 | 3.708B |
| December 31, 2014 | 4.610B |
| September 30, 2014 | 4.748B |
| June 30, 2014 | 5.779B |
| March 31, 2014 | 7.049B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AstraZeneca PLC | 8.051B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
| Pfizer Inc. | 10.99B |
| Sanofi | 9.888B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 3.386B |
| Cash from Investing (Quarterly) | -1.176B |
| Cash from Financing (Quarterly) | -2.542B |
| Free Cash Flow Per Share (Quarterly) | 1.236 |
| Free Cash Flow to Equity (Quarterly) | 3.434B |
| Free Cash Flow to Firm (Quarterly) | 2.892B |
| Free Cash Flow Yield | 6.38% |